PML: underdiagnosed in MS patients on natalizumab.

Steiner, Israel

PML: underdiagnosed in MS patients on natalizumab. [electronic resource] - The Lancet. Neurology Jun 2010 - 564; author reply 564-5 p. digital

Publication Type: Comment; Letter

1474-4465

10.1016/S1474-4422(10)70122-8 doi


Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Disease Progression
Early Diagnosis
Europe--epidemiology
Humans
Immunologic Factors--therapeutic use
Incidence
Leukoencephalopathy, Progressive Multifocal--diagnosis
Multiple Sclerosis--diagnosis
Natalizumab
Review Literature as Topic
United States--epidemiology